Default: Inflammatory Bowel Diseases

ISSN: 1078-0998

Journal Home

Journal Guideline

Inflammatory Bowel Diseases Q1 Unclaimed

Oxford University Press United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Inflammatory Bowel Diseases is a journal indexed in SJR in Immunology and Allergy and Gastroenterology with an H index of 146. It has an SJR impact factor of 1,932 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,932.

Inflammatory Bowel Diseases focuses its scope in these topics and keywords: inflammatory, disease, bowel, patients, crohn?s, clinical, colitis, intestinal, remission, ulcerative, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Inflammatory Bowel Diseases

1,932

SJR Impact factor

146

H Index

332

Total Docs (Last Year)

941

Total Docs (3 years)

9613

Total Refs

3591

Total Cites (3 years)

750

Citable Docs (3 years)

3,59

Cites/Doc (2 years)

28,95

Ref/Doc

Aims and Scope


inflammatory, disease, bowel, patients, crohn?s, clinical, colitis, intestinal, remission, ulcerative, response, pediatric, activity, factor, mucosal, conventional, crohn’s, tumor, studyincreased, marker, multicenter, patient, prevalence, prospective, therapy, thioguanine,



Best articles by citations

THREE STRIKES AND YOU'RE OUT - INTERLEUKIN-10 IN CROHN'S DISEASE

View more

CROHN'S DISEASE AND IL-10 THERAPY: PROMISE REGAINED?

View more

GROWTH OF AN IBD CONTROVERSY: GROWTH HORMONE AND CROHN'S DISEASE

View more

AN ENHANCED BARRIER IS A BETTER DEFENSE: EFFECTS OF PROBIOTICS ON INTESTINAL BARRIER FUNCTION

View more

Intravenous Cyclosporine in Refractory Pyoderma Gangrenosum Complicating Inflammatory Bowel Disease

View more

Intravenous Cyclosporine in Severe Ulcerative Colitis: How Low Can You Go?

View more

Crohn's Jejunoileitis: The Pediatrician's Perspective on Diagnosis and Management

View more

Colonoscopic Findings in Intestinal Behçet's Disease

View more

Epstein-Barr Virus Viral Load in Crohn's Disease

View more

Interleukin-2-Deficient Mice Develop Colitis in the Absence of CD28 Costimulation

View more

Intra- and Interobserver Variation in the Use of the Vienna Classification of Crohn's Disease

View more

Mechanisms of Infliximab

View more
SHOW MORE ARTICLES

Is Infliximab Effective for Induction of Remission in Patients with Ulcerative Colitis?

View more

CHRONIC DIARRHEA: TO SCOPE OR NOT TO SCOPE?

View more

Immune Sensitization to Yeast Antigens in ASCA-positive Patients with Crohn's Disease

View more

Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: Prevalence and risk factors

View more

The Incidence of Lymphoid and Myeloid Malignancies Among Hospitalized Crohn's Disease Patients

View more

Medical Management of Fulminant Colitis

View more

Novel Biological Strategies in Inflammatory Bowel Diseases

View more

Ocular Manifestations of Inflammatory Bowel Disease

View more

WHAT YOU DON'T KNOW MIGHT HURT YOU...

View more

Giving the NOD to a New Understanding of Crohn's Disease: Mother Nature Has Finally Started to Show her CARDs

View more

Support for Suppositories

View more

Mucosal Immunity in Crohn's Disease

View more

Comments

No comments ... Be the first to comment!

FAQS